These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Expression of pi-class glutathione S-transferase: two populations of high grade prostatic intraepithelial neoplasia with different relations to carcinoma. Montironi R; Mazzucchelli R; Stramazzotti D; Pomante R; Thompson D; Bartels PH Mol Pathol; 2000 Jun; 53(3):122-8. PubMed ID: 10897330 [TBL] [Abstract][Full Text] [Related]
24. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. Bell DA; Taylor JA; Paulson DF; Robertson CN; Mohler JL; Lucier GW J Natl Cancer Inst; 1993 Jul; 85(14):1159-64. PubMed ID: 8320745 [TBL] [Abstract][Full Text] [Related]
25. Transitional cell carcinoma of the prostate. Algaba F; Santaularia JM; Lamas M; Ayala G Eur Urol; 1985; 11(2):87-90. PubMed ID: 3891355 [TBL] [Abstract][Full Text] [Related]
26. Palliative care in urology. Wu JN; Meyers FJ; Evans CP Surg Clin North Am; 2011 Apr; 91(2):429-44, x. PubMed ID: 21419262 [TBL] [Abstract][Full Text] [Related]
27. Urothelial carcinoma in the prostatic urethra and prostate: current controversies. Liedberg F; Chebil G; Månsson W Expert Rev Anticancer Ther; 2007 Mar; 7(3):383-90. PubMed ID: 17338657 [TBL] [Abstract][Full Text] [Related]
29. Radioimmunoassay of creatine kinase B-isoenzymes in serum of patients with azotemia, obstructive uropathy, or carcinoma of the prostate or bladder. Homburger HA; Miller SA; Jacob GL Clin Chem; 1980 Dec; 26(13):1821-4. PubMed ID: 6159995 [TBL] [Abstract][Full Text] [Related]
30. Invasive bladder carcinoma: progress in basic research, surgical and medical therapy. Ratliff TL; Rao GS; Ritchey JK Eur Urol; 1998; 33 Suppl 4():15. PubMed ID: 9615201 [No Abstract] [Full Text] [Related]
31. Pathologic assessment and clinical significance of prostatic involvement by transitional cell carcinoma and prostate cancer. Lerner SP; Shen S Urol Oncol; 2008; 26(5):481-5. PubMed ID: 18774459 [TBL] [Abstract][Full Text] [Related]
33. BCG in management of transitional cell carcinoma invasive to prostate. Siami P; Chinn S; Clayton M; Ray V; Rubenstein M; Guinan P Urology; 1989 Dec; 34(6):381-2. PubMed ID: 2595884 [TBL] [Abstract][Full Text] [Related]
34. Cancer of the urogenital tract: bladder cancer. The accuracy of clinical vs. surgical staging. Baker R JAMA; 1968 Nov; 206(8):1770-3 passim. PubMed ID: 5754828 [No Abstract] [Full Text] [Related]
35. Transitional cell carcinoma: a common sense approach. Badalament RA J Urol; 1995 Jan; 153(1):61-2. PubMed ID: 7966792 [No Abstract] [Full Text] [Related]
36. [What's new in urology?]. Hautmann R Urologe A; 1986 Nov; 25(6):305-14. PubMed ID: 2433830 [No Abstract] [Full Text] [Related]
37. [Detection of hypermethylated gene promotors in diagnosis of prostate cancer]. Eilers T; Machtens S; Tezval H; Blaue C; Lichtinghagen R; Hagemann J; Jonas U; Serth J Urologe A; 2007 Sep; 46(9):1077. PubMed ID: 17665167 [No Abstract] [Full Text] [Related]
38. [A case of synchronous triple primary cancers of prostate, kidney and bladder]. Harima M; Narita K; Kobayakawa H; Tsujino T; Yamamoto S; Fukushima S; Kishimoto T Hinyokika Kiyo; 1998 Sep; 44(9):675-8. PubMed ID: 9805676 [TBL] [Abstract][Full Text] [Related]
39. Carcinoembryonic antigen in patients with urologic cancers. Guinan P; Ablin RJ; Barakat H; John T; Sadoughi N; Bush IM Urol Res; 1973 Oct; 1(3):101-5. PubMed ID: 4804082 [No Abstract] [Full Text] [Related]
40. Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids. Goessl C; Krause H; Müller M; Heicappell R; Schrader M; Sachsinger J; Miller K Cancer Res; 2000 Nov; 60(21):5941-5. PubMed ID: 11085508 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]